InvestorsHub Logo
icon url

L0tsaluck2000

04/20/22 2:48 PM

#375207 RE: marjac #375201

While it might be fun to imply that a correction of the cropped table would have resulted in a different judge Du decision, I would proffer that she would have simply found another reason to justify her decision. Each judge has successfully found a reason to not support AMRN's patents.

In every court action the facts and the law were on AMRN's side, but the verdicts weren't.

I was testing how thin your skin was. I supported your actions including a contribution, and was impressed with how you handled your presentation. But be careful to not let your emotions run amuck.
icon url

concapk

04/20/22 6:52 PM

#375221 RE: marjac #375201

marjac,

I just reviewed the defendant's Post Trial Briefs sent to Judge Du ( Feb 28-29, 2020 ).... all I saw was reference to the Karabashi studies along with Mori study concerning or referencing LDL neutral results, with DHA raising LDL.... I didn't see the tables of both Mori/Karabashi included, only referenced.... which would lead to only knowing the original study table results were included in pre-trial briefs....

Could the defendants have included the cropped table in paperwork ( post trial briefs ) sent to the Judge of which she referenced in her decision.... Amarin only saw the cropped table like us when she gave her decision......